Your browser doesn't support javascript.
loading
Towards reproducible computational drug discovery.
Schaduangrat, Nalini; Lampa, Samuel; Simeon, Saw; Gleeson, Matthew Paul; Spjuth, Ola; Nantasenamat, Chanin.
Afiliação
  • Schaduangrat N; Center of Data Mining and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, 10700, Bangkok, Thailand.
  • Lampa S; Department of Pharmaceutical Biosciences, Uppsala University, 751 24, Uppsala, Sweden.
  • Simeon S; Interdisciplinary Graduate Program in Bioscience, Faculty of Science, Kasetsart University, 10900, Bangkok, Thailand.
  • Gleeson MP; Department of Biomedical Engineering, Faculty of Engineering, King Mongkut's Institute of Technology Ladkrabang, 10520, Bangkok, Thailand. paul.gl@kmitl.ac.th.
  • Spjuth O; Department of Pharmaceutical Biosciences, Uppsala University, 751 24, Uppsala, Sweden. ola.spjuth@farmbio.uu.se.
  • Nantasenamat C; Center of Data Mining and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, 10700, Bangkok, Thailand. chanin.nan@mahidol.edu.
J Cheminform ; 12(1): 9, 2020 Jan 28.
Article em En | MEDLINE | ID: mdl-33430992
The reproducibility of experiments has been a long standing impediment for further scientific progress. Computational methods have been instrumental in drug discovery efforts owing to its multifaceted utilization for data collection, pre-processing, analysis and inference. This article provides an in-depth coverage on the reproducibility of computational drug discovery. This review explores the following topics: (1) the current state-of-the-art on reproducible research, (2) research documentation (e.g. electronic laboratory notebook, Jupyter notebook, etc.), (3) science of reproducible research (i.e. comparison and contrast with related concepts as replicability, reusability and reliability), (4) model development in computational drug discovery, (5) computational issues on model development and deployment, (6) use case scenarios for streamlining the computational drug discovery protocol. In computational disciplines, it has become common practice to share data and programming codes used for numerical calculations as to not only facilitate reproducibility, but also to foster collaborations (i.e. to drive the project further by introducing new ideas, growing the data, augmenting the code, etc.). It is therefore inevitable that the field of computational drug design would adopt an open approach towards the collection, curation and sharing of data/code.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: J Cheminform Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Tailândia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: J Cheminform Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Tailândia País de publicação: Reino Unido